Literature DB >> 11807718

Stimulation of cytokine release and adhesion molecule expression by products of Viridans streptococci.

W P Hanage1, J Cohen.   

Abstract

The viridans streptococci (VS) are associated with the development of a rapidly fulminant shock syndrome in neutropenic patients. A panel of 52 VS strains isolated from the blood of neutropenic patients was used to demonstrate the ability of culture supernatants and cell walls of VS to induce release of the proinflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-8 from whole blood in a dose- and strain-dependent fashion. Intercellular adhesion molecule-1 was shown to be markedly up-regulated on endothelial cells after incubation with plasma from blood exposed to cell walls or culture supernatants. This up-regulation was blocked by IL-1 receptor antagonist but not neutralizing antibody against TNF-alpha. These data may help explain the pathogenesis of the viridans streptococcal shock syndrome in neutropenic patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807718     DOI: 10.1086/338375

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis.

Authors:  Hong-Zhou Lu; Xin-Hua Weng; Bai Zhu; Haijing Li; You-Kuan Yin; Yong-Xin Zhang; David W Haas; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  The Role of Corticosteroids in Adult Respiratory Distress Syndrome caused by Viridans Group Streptococci Bacteremia in Neutropenic Patients.

Authors:  Abraham T Yacoub; Lysenia Mojica; Lily Jones; Andrea Knab; Sally Alrabaa; John Greene
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-09-01       Impact factor: 2.576

3.  Assigning strains to bacterial species via the internet.

Authors:  Cynthia J Bishop; David M Aanensen; Gregory E Jordan; Mogens Kilian; William P Hanage; Brian G Spratt
Journal:  BMC Biol       Date:  2009-01-26       Impact factor: 7.431

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.